News

Published on 6 Oct 2024 on GuruFocus.com · via Yahoo Finance

Federated Hermes, Inc. Expands Stake in SCYNEXIS Inc

Article preview image

Overview of Recent Transaction

Federated Hermes, Inc., a prominent institutional investor, recently increased its holdings in SCYNEXIS Inc (NASDAQ:SCYX) by acquiring an additional 2,913,550 shares. This transaction, which took place on September 30, 2024, was executed at a price of $1.49 per share, bringing the firm's total ownership to 7,128,250 shares. This move reflects a strategic addition, enhancing the firm's stake in the biopharmaceutical sector.

Profile of Federated Hermes, Inc.

Read the rest of the article
NYSE.FHI price evolution
NASDAQ.SCYX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Federated Hermes, Inc. Expands Stake in SCYNEXIS Inc

Overview of Recent Transaction Federated Hermes, Inc., a prominent institutional investor, recent...

GuruFocus.com · via Yahoo Finance 6 Oct 2024
Investors in SCYNEXIS (NASDAQ:SCYX) have unfortunately lost 87% over the last five years

Long term investing is the way to go, but that doesn't mean you should hold every stock forever. ...

Simply Wall St. via Yahoo Finance 8 May 2024
Shareholders in SCYNEXIS (NASDAQ:SCYX) are in the red if they invested five years ago

We're definitely into long term investing, but some companies are simply bad investments over any...

Simply Wall St. via Yahoo Finance 30 Nov 2023
SCYNEXIS, Inc.'s (NASDAQ:SCYX) Stock Is Going Strong: Have Financials A Role To Play?

SCYNEXIS' (NASDAQ:SCYX) stock is up by a considerable 18% over the past three months. As most wou...

Simply Wall St. via Yahoo Finance 12 Sep 2023
SCYNEXIS (SCYX) Skyrockets 134% Year to Date: Here's Why

SCYNEXIS’ SCYX shares have surged 133.6% year to date against the industry's 1.9% decline. <img a...

Zacks via Yahoo Finance 4 Sep 2023
Avalo Therapeutics, Inc. (AVTX) Reports Q2 Loss, Misses Revenue Estimates

Avalo Therapeutics, Inc. (AVTX) came out with a quarterly loss of $0.59 per share versus the Zack...

Zacks via Yahoo Finance 3 Aug 2023
Scynexis (SCYX) Reports Q1 Loss, Misses Revenue Estimates

Scynexis (SCYX) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Esti...

Zacks via Yahoo Finance 11 May 2023
SCYNEXIS, Inc.'s (NASDAQ:SCYX) largest shareholders are individual investors with 51% ownership,...

Key Insights The considerable ownership by individual investors in SCYNEXIS indicates that they c...

Simply Wall St. via Yahoo Finance 8 May 2023
We Might See A Profit From SCYNEXIS, Inc. (NASDAQ:SCYX) Soon

SCYNEXIS, Inc. (NASDAQ:SCYX) is possibly approaching a major achievement in its business, so we w...

Simply Wall St. via Yahoo Finance 12 Apr 2023
Scynexis (SCYX) Inks Antifungal Drug Deal With GSK

Shares of Scynexis SCYX surged almost 76% on Mar 30, after it entered an exclusive license agreem...

Zacks via Yahoo Finance 31 Mar 2023

Copyright Statfolio @ 2024

Social Accounts